Synergy's Incoming FDA Catalyst By: Benzinga via Benzinga December 05, 2016 at 14:53 PM EST Timothy Chiang of BTIG remains Buy-rated on Synergy Pharmaceuticals Inc (NASDAQ: SGYP) ahead of the company's Phase 3 data for ... Read More >> Related Stocks: Synergy Pharma